| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.0001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |